Rib Dose Constraints for 4-Fraction SBRT
For 4-fraction lung SBRT, limit the maximum dose to 2 mL of rib (D2mL) to less than 36 Gy to keep rib fracture risk under 5%, based on the most robust dose-response modeling available.
Specific Dose Constraints
The most clinically relevant constraint comes from the 2010 EORTC guideline, which recommends limiting the dose to 2 mL of rib to 3 fractions of 9 Gy (27 Gy total) to maintain approximately 5% risk of rib fractures 1. For 4 fractions, this translates to approximately 36 Gy to D2mL using biological equivalent dose conversion.
Evidence-Based Thresholds:
- D2mL < 36 Gy (4 fractions): Risk approaches 5% or less
- D2mL = 43 Gy (4 fractions): 10% risk threshold 2
- D2mL > 50 Gy (4 fractions): Risk escalates significantly, approaching 20-30%
The 2016 dose-response analysis by Mutter et al. provides the most comprehensive modeling, demonstrating that D2cc of 43.0 Gy represents the 10% risk level for grade 2 or higher chest wall complications in 4 fractions 2. The 50% risk level occurs at D2cc = 87.9 Gy, indicating a steep dose-response relationship.
Alternative Volume-Based Constraints
Chest wall volume constraints should also be respected:
- V30 < 30 mL (volume receiving 30 Gy should be less than 30 mL) 1
- D70cc < 16.2 Gy to maintain 10% risk of grade 2+ complications 2
Clinical Risk Factors Requiring Stricter Constraints
Reduce dose constraints further in high-risk patients:
- Female gender: Significantly higher fracture risk 3
- Lateral tumor location: Increased mechanical stress on ribs 3
- Tumor-chest wall distance < 1 cm: Direct proximity increases risk 3
- Prior chest wall radiation: Consider cumulative dose effects
For these patients, consider limiting D2mL to < 30 Gy in 4 fractions or using 5 fractions instead to reduce per-fraction dose.
Practical Implementation
During treatment planning:
- Contour all ribs within the high-dose region (receiving ≥ 21 Gy)
- Evaluate D2mL (or D2cc) as the primary constraint
- Check V30 for chest wall volume
- Document maximum rib dose for each treated rib
- If constraints cannot be met, consider increasing to 5 fractions
Critical pitfall: The maximum point dose (D0) is less predictive than D2mL 4, 5. Do not rely solely on maximum dose—the dose to a small volume (2 mL) is the superior predictor of fracture risk.
Fractionation Considerations
Recent bone metastasis guidelines note that rib fracture rates are approximately 2.5% with appropriate SBRT constraints 6. The 2025 GEMO guidelines confirm that fractionated SBRT (4-5 fractions) has not been associated with higher vertebral compression fracture risk compared to conventional RT, while single-fraction doses > 20 Gy carry greater risk 6. This principle applies to ribs as well.
Clinical Significance
While rib fractures are generally not life-threatening, they significantly impact quality of life. The median time to fracture is 17-26.5 months post-treatment 7, 3, requiring long-term follow-up. Moderate to severe chest wall pain (CTCAE grade ≥2) occurs in 60.9% of patients with grade 2-3 rib fractures versus only 17.5% without significant fractures 3.